Optomed Oyj (OPTOMED.HE)
EUR 3.95
(3.27%)
EUR 3.95
(3.27%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.35 Million EUR | -37.22% |
| 2022 | 5.34 Million EUR | -18.67% |
| 2021 | 6.57 Million EUR | -5.75% |
| 2020 | 6.97 Million EUR | -20.78% |
| 2019 | 8.8 Million EUR | 136.59% |
| 2018 | 3.72 Million EUR | -31.09% |
| 2017 | 5.39 Million EUR | 81.08% |
| 2016 | 2.98 Million EUR | 2.33% |
| 2015 | 2.91 Million EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 2.06 Million EUR | -12.56% |
| 2024 Q2 | 1.83 Million EUR | -11.37% |
| 2023 Q3 | 3.28 Million EUR | -28.07% |
| 2023 Q4 | 3.35 Million EUR | 2.19% |
| 2023 Q1 | 4.93 Million EUR | -7.71% |
| 2023 Q2 | 4.56 Million EUR | -7.46% |
| 2023 FY | 3.35 Million EUR | -37.22% |
| 2022 Q4 | 5.34 Million EUR | 3.83% |
| 2022 Q2 | 6.33 Million EUR | 0.92% |
| 2022 FY | 5.34 Million EUR | -18.67% |
| 2022 Q3 | 5.14 Million EUR | -18.73% |
| 2022 Q1 | 6.27 Million EUR | -4.5% |
| 2021 Q4 | 6.57 Million EUR | 2.16% |
| 2021 FY | 6.57 Million EUR | -5.75% |
| 2021 Q3 | 6.43 Million EUR | 15.27% |
| 2021 Q1 | 6.33 Million EUR | -9.15% |
| 2021 Q2 | 5.58 Million EUR | -11.9% |
| 2020 FY | 6.97 Million EUR | -20.78% |
| 2020 Q2 | 6.89 Million EUR | -1.09% |
| 2020 Q3 | 6.72 Million EUR | -2.48% |
| 2020 Q4 | 6.97 Million EUR | 3.66% |
| 2020 Q1 | 6.97 Million EUR | -20.77% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 FY | 8.8 Million EUR | 136.59% |
| 2019 Q4 | 8.8 Million EUR | -1.51% |
| 2019 Q3 | 8.93 Million EUR | 0.0% |
| 2018 Q4 | 3.72 Million EUR | 0.0% |
| 2018 FY | 3.72 Million EUR | -31.09% |
| 2017 FY | 5.39 Million EUR | 81.08% |
| 2016 FY | 2.98 Million EUR | 2.33% |
| 2015 FY | 2.91 Million EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|